RBM Nets Biomarker Milestone in Ongoing CNS PGx Collaboration with Roche

The company used its DiscoveryMAP quantitative immunoassay platform to identify a promising multi-protein biomarker pattern using blood samples provided by Roche from a late-stage drug trial.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.